Holen Sie sich die Stockscreener-App
0.7584
6.92%
0.0491
Handel nachbörslich:
.76
0.0016
+0.21%
Ocugen Inc Aktie (OCGN) Neueste Nachrichten
Ocugen Reports Progress in Q1 2025 with Advancements in Gene Therapy - MSN
Ocugen Provides Business Update with First Quarter 2025 Financial Results - ADVFN
Ocugen to Host Q1 2025 Earnings Call and Business Update on May 9 - MSN
Ocugen stock price target cut to $7 by H.C. Wainwright - Investing.com Canada
Ocugen (OCGN) Receives Ongoing "Buy" Rating from Chardan Capital - GuruFocus
Ocugen (OCGN) Maintains 'Buy' Rating Despite Price Target Adjust - GuruFocus
Ocugen (OCGN) Price Target Reduced by H.C. Wainwright | OCGN Sto - GuruFocus
The Analyst Verdict: Ocugen In The Eyes Of 5 Experts - Benzinga
Ocugen outlines 2025 milestones for gene therapy programs with BLA filings on track - MSN
Ocugen, Inc. (NASDAQ:OCGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Ocugen: Q1 Earnings Snapshot - New Haven Register
Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... - Yahoo
Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises By Investing.com - Investing.com India
Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... By GuruFocus - Investing.com Canada
Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises - Investing.com
Ocugen’s Q1 2025: Progress in Gene Therapy Trials - TipRanks
Ocugen Inc’s Earnings Call: Optimism Amid Financial Challenges - TipRanks
Ocugen Provides Business Update with First Quarter 2025 Financia - GuruFocus
Ocugen Q1 2025 Earnings Call Transcript - MarketBeat
Ocugen (OCGN) Reveals Strong Q1 Revenue Growth and Strategic Cli - GuruFocus
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish By Stocktwits - Investing.com India
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish - MSN
Ocugen (OCGN) Set to Release Q1 Earnings with Minimal Revenue Ex - GuruFocus
A Look at Ocugen's Upcoming Earnings Report - Nasdaq
Ocugen (OCGN) Set to Release Q1 Earnings with Minimal Revenue Expectations - GuruFocus
Ocugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology Conferences - MSN
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET - GuruFocus
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results | OCGN Stock News - GuruFocus
Ocugen, Inc. to Host Conference Call for Q1 2025 Financial Results and Business Update - Nasdaq
Ocugen to Host Conference Call on Friday, May 9 at 8:30 - GlobeNewswire
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results - TradingView
Ocugen to Present at Eyecelerator Conference May 2025 - TipRanks
Ocugen to Present on Modifier Gene Therapy Platform at Associati - GuruFocus
OCUGEN Earnings Preview: Recent $OCGN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress - Ocugen
Stock Quote & Chart - Ocugen
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):